KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Travere Therapeutics (TVTX) Return on Invested Capital: 2015-2025

Historic Return on Invested Capital for Travere Therapeutics (TVTX) over the last 5 years, with Sep 2025 value amounting to -1.04%.

  • Travere Therapeutics' Return on Invested Capital was N/A to -1.04% in Q3 2025 from the same period last year, while for Sep 2025 it was -1.04%, marking a year-over-year change of. This contributed to the annual value of -0.70% for FY2020, which is 21.00% down from last year.
  • According to the latest figures from Q3 2025, Travere Therapeutics' Return on Invested Capital is -1.04%, which was up 38.59% from -1.69% recorded in Q2 2025.
  • Over the past 5 years, Travere Therapeutics' Return on Invested Capital peaked at -0.64% during Q2 2021, and registered a low of -1.98% during Q1 2025.
  • In the last 1 years, Travere Therapeutics' Return on Invested Capital had a median value of -1.69% in 2025 and averaged -1.57%.
  • Data for Travere Therapeutics' Return on Invested Capital shows a maximum YoY plummeted of 51bps (in 2021) over the last 5 years.
  • Over the past 2 years, Travere Therapeutics' Return on Invested Capital (Quarterly) stood at -0.73% in 2021, then followed by -1.04% in 2025.
  • Its last three reported values are -1.04% in Q3 2025, -1.69% for Q2 2025, and -1.98% during Q1 2025.